The growing popularity of weight-loss medications like GLP-1s has triggered a broad reevaluation of the driving forces behind our relationship with food. As a result, researchers are also taking a fresh look at the neurological and psychological drivers of eating disorders — including binge-spectrum eating disorders, which affect approximately 2.8 million adults in the United States.
